logo
  

Total Inks 40-yr Onshore Concession Deal With United Arab Emirates And ADNOC

French oil and gas company Total S.A. (TOT, TTFNF,TTA.L) has inked a new 40-year onshore concession agreement with the Supreme Petroleum Council of the Emirate of Abu Dhabi (United Arab Emirates) and the Abu Dhabi National Oil Company or ADNOC, granting Total a 10% participating interest effective January 1, 2015. The concession includes the fifteen principal onshore oil fields of Abu Dhabi and represents more than half of the Emirate's production.

"Total's entry into the new ADCO concession is a major milestone in the history of the Group's 75-year partnership with the Emirate of Abu Dhabi. We are committed to bringing our most advanced technological expertise to unlock the full production potential of Abu Dhabi's onshore fields and therefore contribute to the development of additional reserves over the next 40 years," explained Patrick Pouyanné, Chief Executive of Total.

The new concession would be operated by the Abu Dhabi Company for Onshore Petroleum Operations Ltd. or ADCO, a new operating company in which Total will be a 10% stakeholder. Total has also been appointed Asset Leader for the Bu Hasa and Southeast fields, which represent about two-thirds of ADCO's production.

In 2015, ADCO's expected production is around 1.6 million barrels of oil per day (Mb/d), with an objective to increase output to 1.8 Mb/d from 2017.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT